Developing Degraders for Cancer Immunotherapy
The aim of this project is to engineer a cell-penetrating protein-based therapy that triggers the targeted degradation of immunosuppressive agents to aid in the treatment of cancer.
| K. Dane Wittrup, Ph.D. C. P. Dubbs Professor of Chemical Engineering and Bioengineering Associate Director, Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology Building 76-261 500 Main Street, Cambridge, MA 02139 |
Office Phone: 617-253-4578 |
| Affiliations: Department of Chemical Engineering Department of Biological Engineering Koch Institute for Integrative Cancer Research |